Atara Biotherapeutics
ATRA
ATRA
86 hedge funds and large institutions have $519M invested in Atara Biotherapeutics in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.42% more ownership
Funds ownership: 3.48% → 3.9% (+0.42%)
74% less call options, than puts
Call options by funds: $750K | Put options by funds: $2.85M
Holders
86
Holding in Top 10
–
Calls
$750K
Puts
$2.85M
Top Buyers
| 1 | +$17.1M | |
| 2 | +$7.24M | |
| 3 | +$6.72M | |
| 4 |
Morgan Stanley
New York
|
+$5.41M |
| 5 |
NC
Nexthera Capital
New York
|
+$5.19M |
Top Sellers
| 1 | -$1.86M | |
| 2 | -$1.81M | |
| 3 | -$1.8M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$1.33M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$936K |